7:04 PM
Mar 30, 2009
 |  BC Extra  |  Financial News

Myriad added to AMEX Biotechnology Index

Myriad (NASDAQ:MYGN) replaced Genentech in the AMEX Biotechnology Index. Last Thursday,...

Read the full 36 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >